4Patrignani P, Sciulli MG,Manarini S, etl. COX-2 is not involved in thromboxane biosynthesis by activated human platelets[J].J Physiol Pharmacol,1999,50:661-7.
5Newman PJ, Derbes RS, Astor RH. The human platelet alloantigens PIA1 and PIA2 are associated with a leucine33/proline33 amino acid polymorphism ion membrane glycoprotein Ⅲa and are distinguishable by DNA typing[J].J Clin Invest,1989,83:1778-81.
6Undas A, Brummel K, Musial J, Mann KG, Maurer G, Mayr WR. PIA polymorphism of β3 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury[J].Circulaiton,2001,104:2666-72.
7Undas A, Sanak M, Musial J, Szczeklik. Platlet glycoprotein Ⅲa polymorphism, aspirin,and thrombin generation[J].Lancet,1999,353:982.
8Li N, HU H, Hjemdahl P: Aspirin treatment does not alternate platelet or leukocyte activation as monitored by whole blood flow cytometry[J].Thromb Res,2003,111:165-170.
9Valles J,Santos MT, Aznar J, et al. Erythrocyte metabolically enhance collagen-induced platelet responsiveness via thromboxane production, adenosine diphosphate release recruitment[J].Blood,1991,78;154-162.
10KAWASAKI t,Ozeki Y,Igawa T,Kambayashi J:Increased platelet sensitivity to collagen in individual resistant to low-dose aspirin[J].Stroke 2000,31:591-5.
